Podcasts about clinical trials research

Professor Parry Guilford is known for successfully in identifying the first known genetic mutations in the CDH1 gene, leading to the description of a new cancer syndrome Hereditary Diffuse Gastric Cancer (HDGC). This discovery has conservatively saved 27,000 people from developing a severe form of stomach cancer. Parry is determined to continue to change the course of HDGC stomach cancer patients outcomes, he is invested in the CDH1 mutation families and feels their trials as if they were his own. We discuss genetic counselling, the age at which we test our children for hereditary cancers, his work on lobular breast cancer, bowel cancer and funding research. 

Drs. Russell Rothman and Erin Holve discuss a decade of research in PCORnet®.

After a long, pandemic-induced lull, attorney conferences have made a comeback. These events provide LNCs with a unique opportunity to meet prospective clients face to face. Angel Hickerson and your host, Pat Iyer, share advice on how to get the most out of these exhibiting conferences. Perhaps the most important recommendation is to be professional in every way. Dress appropriately, stay off your cell phone, don't deluge your prospect with too much information about your practice, and make sure the appearance of your booth reflects your business colors. Don't leave your booth unattended; have a companion who can answer questions when you take a needed break. Be patient. If you are at a three-day conference, recognize that the attorneys have a lot to accomplish. If they get to you before you leave, you've succeeded. That same level of patience plus persistence is necessary in the follow-up process. Angel never gives up, and often, three or six months later, the attorney remembers her and gives her a call. This conversation between two veteran conference attendees will give you the information you need to return to one of the most fruitful areas for LNCs looking for new clients. Join me in this episode of Legal Nurse Podcast to learn How to Shine when Exhibiting - Angel Hickerson How can you get through the fear of exhibiting? How does introversion/extroversion affect the ability to successfully engage with attorneys? Why is it important to have someone at the booth with you? How should you dress? How do you answer when an attorney asks what you do? Listen to our podcasts or watch them using our app, Expert.edu, available at legalnursebusiness.com/expertedu. https://youtu.be/7rsftK7tzR8 Join us for our 7th Virtual Conference! LNC Success is a Livecast Virtual Conference 3-day event designed for legal nurse consultants just like you! Pat Iyer and Barbara Levin put together THE first Legal Nurse Consulting Virtual Conference in July 2020. They are back with their 7th all-new conference based on what attendees said they'd find most valuable. This new implementation and networking event is designed for LNCs at any stage in their career. Build your expertise, attract higher-paying attorney clients, and take your business to the next level. After the LNC Success Virtual Conference, you will leave with clarity, confidence, and an effective step-by-step action plan that you can immediately implement in your business. Your Presenter of How to Shine when Exhibiting - Angel Hickerson Angel is the owner and certified legal nurse consultant of Guardian Angel Consulting, LLC, in Albuquerque, New Mexico. She earned her Masters in Nursing in Clinical Trials Research from Drexel University. Her thirteen years of nursing experience have included postpartum OB, high-risk pregnancy, pediatric intensive care, case management, and utilization review. She is also the founder and president of the New Mexico Nurses Honor Guard, a volunteer group that pays tributes to fallen nurses. Connect with Angel at http://www.guardianangel-consulting.com Or Connect with Wendy on LinkedIn and social media Facebook: https://www.facebook.com/profile.php?id=100075994418109 Instagram: instagram.com/guardianangelconsulting LinkedIn: https://www.linkedin.com/in/angel-hickerson-rn-msn-clnc-3847a1224

The power of NMF is its ability to empower and uplift the next generation of healthcare leaders. Listen to how Carmen Villar, Vice President of Social Business Innovation at Merck & Co is #reimagininghealthcar by elevating the intersection of social and business impact while striving to create sustainable health systems to support improved health and well-being globally.  Prior to joining Merck, Carmen was Chief of Staff at the Centers for Disease Control and Prevention (CDC). Carmen led the agency through both the West African Ebola and the Zika emergency responses. Her leadership was critical in providing coordination across the agency and with other US government counterparts and earned her the honor of the Presidential Meritorious Rank Award. She worked in both Nigeria and Zambia, providing leadership and oversight to CDC's programs as part of the President's Emergency Plan for AIDS Relief (PEPFAR). As a key health advisor to the US Ambassadors in Nigeria and Zambia, she also provided expert advice in critical public health areas such as Polio and Tuberculosis.  Carmen started in government as a Presidential Management Fellow focusing on policy and program planning for HIV, STD, and TB prevention. Carmen has also overseen multi-site domestic and international HIV research projects in the areas of drug use, prevention of mother-to-child treatment, and vaccines. Prior to joining the CDC, she was the Policy Affairs Coordinator at the AIDS Healthcare Foundation and had also served as a Legislative Aide in the California Assembly. Carmen holds a Master's in Social Welfare from UC Berkeley and a Bachelor's in Anthropology from UC Berkley. She is currently a Board Member of NMF. National Medical Fellowships, Inc. believes a just and equitable world requires diverse healthcare leaders who not only bring diverse representation to the medical field but also lead the fight to eliminate health disparities.  You can learn more about NMF at www.nmfonline.org

This episode features Dr. Elizabeth Fox, SVP Clinical Trials Research, St. Jude Children's Research Hospital. Here, she discusses her focus on mentoring the next generation of clinicians, St. Jude Children's research on innovative cellular therapies, how the pandemic has impacted clinical research, and more.

This episode features Dr. Elizabeth Fox, SVP Clinical Trials Research, St. Jude Children's Research Hospital. Here, she discusses her focus on mentoring the next generation of clinicians, St. Jude Children's research on innovative cellular therapies, how the pandemic has impacted clinical research, and more.

Dr. Narendra Singh, cardiologist and a clinical assistant professor at the Medical College of Georgia at Augusta University, also a clinical assistant professor at the College of Health Professions at Mercer University of Atlanta as well as the director of clinical research at NSC cardiology, Johns Creek, Georgia, joins us to discuss various topics in cardiology in this PV Roundup specialist spotlight.

Today  (ibit.ly/Re5V) we talk with Annette Briley about her midwifery career and some of her many clinical trials that have change our practiceResearch link -  ibit.ly/W4Wh#phdmidwives   @tommys @KingsMaternity #midwiferyresearch #clinicaltrials @FlindersCNHS #bigdata @FlindersCFIDo you know someone who should tell their story?email me  - thruthepodcast@gmail.comThe aim is for this to be a fortnightly podcast with extra episodes thrown inThis podcast can be found on twitter - @thruthepinard, insta @thruthepinard and our website -https://thruthepinardpodcast.buzzsprout.com/ or ibit.ly/Re5VSupport the show (https://www.patreon.com/thruthepinardpodcast)Support the showDo you know someone who should tell their story?email me - thruthepodcast@gmail.comThe aim is for this to be a fortnightly podcast with extra episodes thrown inThis podcast can be found on various socials as @thruthepinardd and our website -https://thruthepinardpodcast.buzzsprout.com/ or ibit.ly/Re5V

Samantha was 21 years old when she found out she had the BRCA1 gene mutation. This means she has a 70% risk of developing breast cancer and a 40% risk of developing ovarian cancer. She speaks with us about her decision to be proactive in managing her risk by joining the BRCA-P Clinical Trial.

Let's talk about nursing beyond the bedside! We're so excited to chat with clinical trials research nurse, Jordin Rice! Having gained experience as a bedside nurse, Jordin made the switch to clinical trials research and is sharing how it has helped her grow as a nurse! Along with some behind the scenes of the clinical trials world, Jordin is sharing some incredible advice for all nurses out there...your nursing journey doesn't have to look like anyone else's. Nursing is such an incredible field with so many specialties. There is a place for you to make an impact as a nurse, in a specialty you uniquely feel called to!   01:15 How did you get involved with FIGS? 02:30 Did you always know you wanted to be a nurse? 04:00 Making the switch from bedside to clinical trials research. 07:50 When you applied for the research position, did you know it would be with Pulmonary Hypertension? 09:40 Do you work closely with hospitals around you, or mainly the FDA? 13:15 Have you found most nurses in research have previous bedside experience? 15:00 What does your day-to-day schedule look like? 19:00 What does it take to be a clinical research nurse? 22:15 Helping patients heal from disease beyond their hospital stay. 25:00 Do you find it's hard to find patients to apply for clinical trials, or is there an abundance of applicants? 26:40 What drives you to advocate for others? 29:30 What are some changes you would like to see for clinical research? 31:50 Where research and bedside skills meet! 34:00 You can create your own path in your nursing career! Follow Jordin on Instagram | @jordinrice   Check out the sponsor of today's episode: ATI the creator of the TEAS Exam atitesting.com/teas-prep   Use code: LIFEINSCRUBS to save 15% on any TEAS prep! **Code valid for TEAS products only through August 31st, 2021**   …………………………..   Connect with us on Instagram | @lifeinscrubspodcast   Follow along with our personal Instagram pages too!   Connect with Kristen on Instagram | @thenursekristen    Connect with Maddi on Instagram | @nurse.maddi    

Mathieu Galtier, PhD – Neuroscience and computer science (applied mathematics) background. Chief Product Officer of Owkin which was founded in 2016 and has quickly emerged as a leader in bringing AI and ML technologies to the healthcare industry. We’ll be talking about how blockchain technology and federated learning systems are creating amazing new opportunities in medical research and development. LinkedIn https://www.linkedin.com/in/mgaltier/ Guest Twitter: https://twitter.com/m_galtier Research: https://www.researchgate.net/profile/Mathieu-Galtier MELLODDY: https://www.imi.europa.eu/projects-results/project-factsheets/melloddy Owkin • Origins of Owkin and the healthcare interest - life science company - research oriented - really want to cure cancer o Medical data & Clinical predictive models o Connect platform for Federated Learning • Owkin Tech stack overview o Data prep o Infra: Kubernetes o Application layer: Substra (python, Hyperledger fabric) o Algorithms: any python ML frameworks (pytorch, tensorflow etc) • open source foundation to host Substra framework for distributed computation ML for Healthcare • Why is ML relevant for Healthcare? o Precision medicine: customization of treatment to individual patients based on their medical data. o• Clinical Trials Research challenges and opportunities oFederated Learning for Healthcare • What is Federated Learning? o Model training across distributed datasets. Data is never shared. (opposition centralized computation vs traveling models) o Can you describe how federated learning can solve some of our privacy and security concerns with personal data? o HealthChain project o Melloddy project • What is the HealthChain project's main objective? • MELLODDY consortium - Owkin, NVIDIA, and King’s College London - Have you reached your goals? What's new with this collaboration? • Academic collaboration → HealthChain o Industrial coopetition → Melloddy • BLockchain in Federated Learning • Why is a blockchain relevant for Federated Learning? What is in the blockchain? o Trustless permission regime → smart contracts for details governance / data access regimes o Traceability & reproducibility (no 3rd party to trust) → good for certification o Decentralized orchestration → increase security; no shadow computation o Tokenization of data value through contribution score for training models o Private vs public blockchains: we needed a consortium blockchain o How can blockchain-orchestrated federated learning enable a new method of building AI models? o Models have an identity card describing their genealogy. Their performance can be assessed on 3rd party datasets → models are production / certification ready o Models are the most accurate possible. They serve as the basis (for transfer learning) for numerous data modalities: histology, genomics, chemistry... •What do you believe in that most people would disagree with? o There is no free will • Favorite book that has influenced you o Foundation by Isaac Asimov. Psychohistory: 2 scales individual and population. • Keys to ML in Healthcare  Collaboration  Confidentiality  Compliance News Corner https://www.wired.com/story/microsoft-decentralized-id-blockchain/ Occording to sources, Microsoft has been working on a decentralized identity solution since 2017 and has slowly built out the infrastructure over the past few years.. At the recent Ignite conference, Microsoft announced that it will launch a public preview of its “Azure Active Directory verifiable credentials” spring of 2021. In the NHS pilot, for example, health care providers can request access to professional certifications from existing NHS health care workers, who can in turn choose to allow that access, streamlining a process for transferring to another facility that previously required a much more involved back and forth. U Health Unchained Links Website: https://healthunchained.org Telegram: t.me/healthunchained Twitter: twitter.com/Healthunchaind

In the 11th episode of our COVID-19 series, Bryn talks to Professor Chris Fegan, Director of the Research and Development at Cardiff and Vale UHB. They discuss some of the ongoing trials happening in the Health Board, how COVID-19 has changed the way research is carried out and how it has impacted the trials happening in other areas of healthcare.

Cancer Geneticist Associate Professor Judy Kirk explains the role of genetics in breast cancer research and how this information will help inform future treatments.

Early breast cancer is cancer which is confined to the breast or the axillary (armpit) lymph nodes. It’s a research focus for Dr Stuart McIntosh who explains what the standard treatment is for early breast cancer, what clinical trials are currently investigating early breast cancer treatments and how treatments differ to advanced breast cancer.

Hormone sensitive breast tumors make up around 70% of all breast cancers. Associate Professor Aleix Prat explains what research is being conducted into this metastatic disease and how before we can find a cure, researchers are working in the short term to find a way to make it a chronic disease.

Michelle and Maxine are both participants in the Breast Cancer Trials CHARIOT clinical trial. They are receiving the same treatment, at the same hospital and formed a friendship through their shared experience. They discuss their experience on the trial & how helpful it has been to have a friend by their side.

Heidi started getting mammograms at 42 after a close friend was diagnosed in her early 40s. She was thankful she did, after she was diagnosed with breast cancer at 43. Heidi speaks with us about being diagnosed as a young woman with a young family, having to put your career on hold and not being afraid to ask for help when you need it.

Linda Lopez-George discusses why it is important to improve access and participation in clinical trials among minority and undeserved populations. To view Linda Lopez-George Linkedin go here https://www.linkedin.com/in/linda-lopez-george/ To view UT Health San Antonio please go here https://www.uthscsa.edu/?utm_source=uthealthsaorg&utm_medium=pageredirect&utm_campaign=uthealthsa

Cancer Geneticist Associate Professor Judy Kirk explains who should get genetic testing, what exactly a ‘strong family history’ means and how you can get tested.

Gowri Sivalingam was diagnosed in 2015 with invasive ductal carcinoma after finding a lump in her breast on Christmas day. She spoke with us about being diagnosed with breast cancer as a young woman, working throughout treatment, participating in a clinical trial and what it’s like to be diagnosed with cancer when you are a doctor.

Breast Surgeon at Belfast City Hospital, Dr Stuart McIntosh, discusses clinical trials open in the UK & explains it’s hoped these trials will open in Australia & NZ.

Radiation therapy uses doses of radiation to kill cancer cells & shrink tumors. In this Breast Cancer Trials Podcast, Professor Julia White explains why it is an important part of breast cancer treatment.

Marie Pandeloglou was diagnosed with metastatic breast cancer 4 and a half years after her early breast cancer diagnosis. She shares what it is like to live with metastatic disease, what she wants people to know about metastatic breast cancer, and her advice for those living with breast cancer.

One of the best ways to diagnose breast cancer early, aid in treatment decisions or predict treatment response is to use cancer biomarkers. HER2 positive early breast cancer molecular biomarkers are a research area for Associate Professor Aleix Prat. He explains that investigating HER2 positive early breast cancer is important as it can become an aggressive disease if left untreated.

Breast Cancer Network Australia (BCNA) surveyed 2,000 of its members who have received a breast cancer diagnosis about the out-of-pocket costs of their breast cancer treatment and care, and other associated costs faced in the first five years after a breast cancer diagnosis. We sat down with BCNA's CEO Kirsten Pilatti to find out more about their findings.

Most cancer researchers spend their careers focusing on one disease type. Professor Wayne Tilley has instead specalised in two; breast and prostate cancer. He is renowned for leveraging the commonalities of both to advance knowledge and treatments for both treatment types. He sat down with us to discuss his research.

It’s a common misconception that men can’t get breast cancer, however just under 1% of all breast cancers will occur in men. To help explain how breast cancer occurs and is treated in men - we sat down with Rik Thompson, Professor of Breast Cancer Research and a Breast Cancer Trials Board Member.

A liquid biopsy is a simple and non-invasive alternative to surgical biopsies, which enables doctors to discover a range of information about a tumour through a simple blood sample. We speak with Professor Rik Thompson about how liquid biopsy relates to breast cancer treatment and why it's important in metastatic breast cancer.

Immunotherapy allows cancer to become more visible to the immune system so it can then attack it. The PANACEA trial was Breast Cancer Trials first immunotherapy trial, and it has lead to further research into this area. Listen in to Associate Professor Prue Francis discuss the benefits of this trial, and the future of Immunotherapy in breast cancer care.

A breast cancer diagnosis can come as a huge shock to a young women and the challenges that come with their diagnosis can be different to women at a later stage in life. We speak with Breast Cancer Trials Associate Professor Prue Francis about how common it is for young women to be diagnosed with breast cancer, what challenges come with this diagnosis and how Breast Cancer Trials is working to improve the treatments for those in this age group.

The SOLACE clinical trial was for women or men who had been diagnosed with advanced BRCA-associated breast cancer, triple negative breast cancer or serious ovarian cancer. Listen in to see how these results are informing current research into ovarian and breast cancer.

Did you know women with dense breasts can be five times more likely to develop breast cancer. In this podcast episode, we talk with breast cancer researcher Professor Rik Thompson about mammographic density - who has it, what causes it, and why aren't we more aware of it.

Breast cancer clinical trials have played a significant role in improvements to breast cancer survival rates and treatments over the last 30 years. Breast Cancer Trials Deputy Director of Research, Professor Kelly-Anne Phillips explains that a clinical trial is research in action.

Do you know the symptoms of breast cancer? Do you know what you should do after finding a symptom of breast cancer? In this podcast, Breast Cancer Trials Board Member and Medical Oncologist Associate Professor Nicholas Wilcken discusses the symptoms of breast cancer, and why it's important not to panic if you find a breast abnormality.

In Australia and New Zealand, the number of people of people being diagnosed with breast cancer is increasing. However, the breast cancer mortality rate is in decline, which means less people are dying from this disease. To help make sense of why this is, we sat down with Associate Professor Nicholas Wilcken, a Medical Oncologist and Breast Cancer Trials Board Member.

When we experience a breast cancer diagnosis, or know someone experiencing a diagnosis, we want to say the right thing. But sometimes words like 'fighter', 'warrior' and 'hero' are often not well received. We sat down with two women who have experienced a breast cancer diagnosis to ask what words they like, and dislike, to describe their breast cancer experience.

Finding a clinical trial that is right for you, or for a family member or friend, has never been easier. In this podcast Professor Bruce Mann explains the two main paths to participating in a clinical trial and what’s involved once you’re on a trial. Find our more: www.breastcancertrials.org.au

Metastatic breast cancer – also known as advanced, secondary or stage 4 breast cancer – is breast cancer that has spread beyond the breast to other organs in the body. In this podcast, Professor Rik Thompson discusses why and how cancer metastasises and why it’s so difficult to treat. Learn more: www.breastcancertrials.org.au

Immunotherapy has had incredible success in treating other cancer types, such as melanoma and lung cancer, but is not yet in routine use in the clinic as a treatment option for breast cancer. Learn how immunotherapy works and how the CHARIOT and DIAmOND clinical trials use different combinations of immunotherapy in patients with breast cancer subtypes that are more likely to respond to immune manipulation. Learn more: www.breastcancertrials.org.au

Since becoming a chiropractor Craig Moore completed a Masters of Clinical Trials Research at the University of Sydney and is near the completion of his PhD at the University of Technology Sydney. His PhD study is focussed on the management of headaches and migraine by chiropractors from a public health and epidemiological perspective. His headache Listen In The post BC 43: Dr Craig Moore Headache – Research with practical applications appeared first on The Wellness Couch.

ONS member Teresa Knoop, MSN, RN, AOCN®, assistant director of clinical trials at Vanderbilt Ingram Cancer Center in Nashville, TN, joins ONS's Barbara Lubejko, MS, RN, to discuss the practical side of clinical trials for oncology nursing, including addressing long-term side effects, handling oncologic emergencies, and working closely with the research team.   Music Credit: "Fireflies and Stardust" Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 3.0 License http://creativecommons.org/licenses/by/3.0   Episode Notes: Check out these resources from today's episode: Manual for Clinical Trials Nursing (3rd edition) Oncology Nurses Drive Change in Cancer Care With Clinical Trials Consider a Role in Clinical Trials Research as an Evolution of Your Nursing Career Oncology Clinical Trials at ONS Voice Clinical Trial Nurses ONS Community Clinical Trials Nurse Competencies Abstract Writing Presentation Slides

Groundbreaking Technology Key for Improving Clinical Studies, Unlocking and Securing Data and Enhancing Patient Safety and Engagement. Learn more about the Blockchain for Clinical Trials Forum.